Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor

Journal of Steroid Biochemistry and Molecular Biology

Volumn 128, Issue 1-2, 2012, Pages 51-55

  Blum, Andreas ^a   Loerz, Christine ^a   Martin, Hans Joerg ^a   Staab Weijnitz, Claudia A ^a   Maser, Edmund ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

11 HSD1 inhibitor; Bitter melon; Diabetes; Hypoglycaemia; Momordica charantia; Traditional medicine

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; 11BETA HYDROXYSTEROID DEHYDROGENASE 2; ANTIDIABETIC AGENT; CORTISONE; ENZYME INHIBITOR; HYDROCORTISONE; MOMORDICA CHARANTIA EXTRACT; SANAKINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG SCREENING; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; LIVER MICROSOME; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORTISONE; DIABETES MELLITUS, TYPE 2; ENZYME ASSAYS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MICROSOMES; MOMORDICA CHARANTIA; OXIDATION-REDUCTION; PLACENTA; PLANT EXTRACTS; PREGNANCY;

CUCUMIS; MOMORDICA CHARANTIA; RODENTIA;

EID: 82755188170     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2011.09.003     Document Type: Article

References (51)

1. P. Zimmet, K.G. Alberti, and J. Shaw Global and societal implications of the diabetes epidemic Nature 414 6865 2001 782 787 (Pubitemid 34000780)
2. S. Wild, G. Roglic, A. Green, R. Sicree, and H. King Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diab. Care 27 5 2004 1047 1053 (Pubitemid 38579764)
3. A. Blum, and E. Maser Enzymology and molecular biology of glucocorticoid metabolism in humans Prog. Nucleic Acid Res. Mol. Biol. 75 2003 173 216 (Pubitemid 137639558)
4. E. Maser, B. Völker, and J. Friebertshäuser 11 Beta-hydroxysteroid dehydrogenase type 1 from human liver: dimerization and enzyme cooperativity support its postulated role as glucocorticoid reductase Biochemistry 41 7 2002 2459 2465 (Pubitemid 34160910)
5. H. Masuzaki, J. Paterson, H. Shinyama, N.M. Morton, J.J. Mullins, J.R. Seckl, and J.S. Flier A transgenic model of visceral obesity and the metabolic syndrome Science 294 5549 2001 2166 2170 (Pubitemid 33150673)
6. M. Wamil, and J.R. Seckl Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target Drug Discov. Today 12 13-14 2007 504 520 (Pubitemid 47031664)
7. C.A. Staab, and E. Maser 11Beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation J. Steroid Biochem. Mol. Biol. 2010
8. Y. Kotelevtsev, M.C. Holmes, A. Burchell, P.M. Houston, D. Schmoll, P. Jamieson, R. Best, R. Brown, C.R. Edwards, J.R. Seckl, and J.J. Mullins 11Beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress Proc. Natl. Acad. Sci. U.S.A. 94 26 1997 14924 14929 (Pubitemid 28041476)
9. N.M. Morton, M.C. Holmes, C. Fievet, B. Staels, A. Tailleux, J.J. Mullins, and J.R. Seckl Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice J. Biol. Chem. 276 44 2001 41293 41300
10. N.M. Morton, J.M. Paterson, H. Masuzaki, M.C. Holmes, B. Staels, C. Fievet, B.R. Walker, J.S. Flier, J.J. Mullins, and J.R. Seckl Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice Diabetes 53 4 2004 931 938 (Pubitemid 38436604)
11. P.M. Stewart, A.M. Wallace, S.M. Atherden, C.H. Shearing, and C.R. Edwards Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11 beta-hydroxysteroid dehydrogenase activity in man Clin. Sci. 78 1 1990 49 54 (Pubitemid 20030050)
12. P.M. Stewart, and C.R. Edwards The cortisol-cortisone shuttle and hypertension J. Steroid Biochem. Mol. Biol. 40 4-6 1991 501 509
13. J.K. Grover, and S.P. Yadav Pharmacological actions and potential uses of Momordica charantia: a review J. Ethnopharmacol. 93 1 2004 123 132 (Pubitemid 38739282)
14. L. Leung, R. Birtwhistle, J. Kotecha, S. Hannah, and S. Cuthbertson Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review Br. J. Nutr. 102 12 2009 1703 1708
15. B.A. Leatherdale, R.K. Panesar, G. Singh, T.W. Atkins, C.J. Bailey, and A.H. Bignell Improvement in glucose tolerance due to Momordica charantia (karela) Br. Med. J. (Clin. Res. Ed.) 282 6279 1981 1823 1824 (Pubitemid 11047735)
16. C. Day, T. Cartwright, J. Provost, and C.J. Bailey Hypoglycaemic effect of Momordica charantia extracts Planta Med. 56 5 1990 426 429 (Pubitemid 20347576)
17. B.A. Shibib, L.A. Khan, and R. Rahman Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase Biochem. J. 292 Part 1 1993 267 270 (Pubitemid 23158992)
18. L. Ali, A.K. Khan, M.I. Mamun, M. Mosihuzzaman, N. Nahar, M. Nur-e-Alam, and B. Rokeya Studies on hypoglycemic effects of fruit pulp, seed, and whole plant of Momordica charantia on normal and diabetic model rats Planta Med. 59 5 1993 408 412 (Pubitemid 23319541)
19. S. Sarkar, M. Pranava, and R. Marita Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes Pharmacol. Res. 33 1 1996 1 4 (Pubitemid 26229602)
20. A.P. Jayasooriya, M. Sakono, C. Yukizaki, M. Kawano, K. Yamamoto, and N. Fukuda Effects of Momordica charantia powder on serum glucose levels and various lipid parameters in rats fed with cholesterol-free and cholesterol-enriched diets J. Ethnopharmacol. 72 1-2 2000 331 336
21. L.L. Chan, Q. Chen, A.G. Go, E.K. Lam, and E.T. Li Reduced adiposity in bitter melon (Momordica charantia)-fed rats is associated with increased lipid oxidative enzyme activities and uncoupling protein expression J. Nutr. 135 11 2005 2517 2523 (Pubitemid 43156589)
22. Q. Chen, L.L. Chan, and E.T. Li Bitter melon (Momordica charantia) reduces adiposity, lowers serum insulin and normalizes glucose tolerance in rats fed a high fat diet J. Nutr. 133 4 2003 1088 1093 (Pubitemid 36407130)
23. Q. Chen, and E.T. Li Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines Br. J. Nutr. 93 5 2005 747 754 (Pubitemid 43906361)
24. A. Blum, H.J. Martin, and E. Maser Human 11beta-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli Toxicology 144 1-3 2000 113 120 (Pubitemid 30201627)
25. M.B. Krawinkel, and G.B. Keding Bitter gourd (Momordica Charantia): a dietary approach to hyperglycemia Nutr. Rev. 64 7 Part 1 2006 331 337 (Pubitemid 44124977)
26. P. Khanna, S.C. Jain, A. Panagariya, and V.P. Dixit Hypoglycemic activity of polypeptide-p from a plant source J. Nat. Prod. 44 6 1981 648 655 (Pubitemid 12152470)
27. V.S. Baldwa, C.M. Bhandari, A. Pangaria, and R.K. Goyal Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant source Ups. J. Med. Sci. 82 1 1977 39 41 (Pubitemid 8098430)
28. T.B. Ng, C.M. Wong, W.W. Li, and H.W. Yeung Insulin-like molecules in Momordica charantia seeds J. Ethnopharmacol. 15 1 1986 107 117 (Pubitemid 16173406)
29. J. Welihinda, and E.H. Karunanayake Extra-pancreatic effects of Momordica charantia in rats J. Ethnopharmacol. 17 3 1986 247 255
30. T. Miura, C. Itoh, N. Iwamoto, M. Kato, M. Kawai, S.R. Park, and I. Suzuki Hypoglycemic activity of the fruit of the Momordica charantia in type 2 diabetic mice J. Nutr. Sci. Vitaminol. (Tokyo). 47 5 2001 340 344 (Pubitemid 33139560)
31. S.S. Rathi, J.K. Grover, and V. Vats The effect of Momordica charantia and Mucuna pruriens in experimental diabetes and their effect on key metabolic enzymes involved in carbohydrate metabolism Phytother. Res. 16 3 2002 236 243 (Pubitemid 34534949)
32. I. Ahmed, E. Adeghate, E. Cummings, A.K. Sharma, and J. Singh Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat Mol. Cell. Biochem. 261 1-2 2004 63 70 (Pubitemid 39004517)
33. E. Cummings, H.S. Hundal, H. Wackerhage, M. Hope, M. Belle, E. Adeghate, and J. Singh Momordica charantia fruit juice stimulates glucose and amino acid uptakes in L6 myotubes Mol. Cell. Biochem. 261 1-2 2004 99 104 (Pubitemid 39004522)
34. S. Yibchok-anun, S. Adisakwattana, C.Y. Yao, P. Sangvanich, S. Roengsumran, and W.H. Hsu Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities Biol. Pharm. Bull. 29 6 2006 1126 1131 (Pubitemid 43845470)
35. P. Meir, and Z. Yaniv An in vitro study on the effect of momordica charantia on glucose uptake and glucose metabolism in rats Planta Med. 51 1 1985 12 16 (Pubitemid 15146405)
36. M.F. Mahomoodally, A. Gurib-Fakim, and A.H. Subratty Effect of exogenous ATP on Momordica charantia Linn. (Cucurbitaceae) induced inhibition of d-glucose, l-tyrosine and fluid transport across rat everted intestinal sacs in vitro J. Ethnopharmacol. 110 2 2007 257 263 (Pubitemid 46283659)
37. M.F. Mahomoodally, A. Gurub-Fakim, and A.H. Subratty Momordica charantia extracts inhibit uptake of monosaccharide and amino acid across rat everted gut sacs in-vitro Biol. Pharm. Bull. 27 2 2004 216 218 (Pubitemid 41694701)
38. I. Ahmed, E. Adeghate, A.K. Sharma, D.J. Pallot, and J. Singh Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat Diab. Res. Clin. Pract. 40 3 1998 145 151 (Pubitemid 28332875)
39. B. Kameswararao, M.M. Kesavulu, and C. Apparao Evaluation of antidiabetic effect of Momordica cymbalaria fruit in alloxan-diabetic rats Fitoterapia 74 1-2 2003 7 13 (Pubitemid 36292137)
40. N.P. Fernandes, C.V. Lagishetty, V.S. Panda, and S.R. Naik An experimental evaluation of the antidiabetic and antilipidemic properties of a standardized Momordica charantia fruit extract BMC Complement. Altern. Med. 7 2007 29
41. H.L. Cheng, H.K. Huang, C.I. Chang, C.P. Tsai, and C.H. Chou A cell-based screening identifies compounds from the stem of Momordica charantia that overcome insulin resistance and activate AMP-activated protein kinase J. Agric. Food Chem. 56 16 2008 6835 6843
42. C.C. Shih, C.H. Lin, and W.L. Lin Effects of Momordica charantia on insulin resistance and visceral obesity in mice on high-fat diet Diab. Res. Clin. Pract. 81 2 2008 134 143
43. C.Y. Chuang, C. Hsu, C.Y. Chao, Y.S. Wein, Y.H. Kuo, and C.J. Huang Fractionation and identification of 9c, 11t, 13t-conjugated linolenic acid as an activator of PPARalpha in bitter gourd (Momordica charantia L.) J. Biomed. Sci. 13 6 2006 763 772 (Pubitemid 44900649)
44. M.G. Sridhar, R. Vinayagamoorthi, V. Arul Suyambunathan, Z. Bobby, and N. Selvaraj Bitter gourd (Momordica charantia) improves insulin sensitivity by increasing skeletal muscle insulin-stimulated IRS-1 tyrosine phosphorylation in high-fat-fed rats Br. J. Nutr. 99 4 2008 806 812 (Pubitemid 351351634)
45. L. Harinantenaina, M. Tanaka, S. Takaoka, M. Oda, O. Mogami, M. Uchida, and Y. Asakawa Momordica charantia constituents and antidiabetic screening of the isolated major compounds Chem. Pharm. Bull. 54 7 2006 1017 1021
46. B. Davani, A. Khan, M. Hult, E. Martensson, S. Okret, S. Efendic, H. Jornvall, and U.C. Oppermann Type 1 11beta -hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets J. Biol. Chem. 275 45 2000 34841 34844
47. H. Ortsater, P. Alberts, U. Warpman, L.O. Engblom, L. Abrahmsen, and P. Bergsten Regulation of 11beta-hydroxysteroid dehydrogenase type 1 and glucose-stimulated insulin secretion in pancreatic islets of Langerhans Diab. Metab. Res. Rev. 21 4 2005 359 366 (Pubitemid 40945958)
48. A. Swali, E.A. Walker, G.G. Lavery, J.W. Tomlinson, and P.M. Stewart 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets Diabetologia 51 11 2008 2003 2011
49. J.M. Stafford, M. Waltner-Law, and D.K. Granner Role of accessory factors and steroid receptor coactivator 1 in the regulation of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids J. Biol. Chem. 276 6 2001 3811 3819
50. P. Alberts, L. Engblom, N. Edling, M. Forsgren, G. Klingstrom, C. Larsson, Y. Ronquist-Nii, B. Ohman, and L. Abrahmsen Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice Diabetologia 45 11 2002 1528 1532 (Pubitemid 35352046)
51. S.A. Morgan, M. Sherlock, L.L. Gathercole, G.G. Lavery, C. Lenaghan, I.J. Bujalska, D. Laber, A. Yu, G. Convey, R. Mayers, K. Hegyi, J.K. Sethi, P.M. Stewart, D.M. Smith, and J.W. Tomlinson 11{beta}-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle Diabetes 2009